Localization of tenascin in human skin wounds by Betz, P. et al.
Int J Leg Med (1993) 105 :325-328 
International Journal of 
Legal Medicine 
© Springer-Verlag 1993 
Local izat ion of  tenascin in human skin wounds  - 
an immunohis tochemica l  study 
P. Betz 1, A. Nerlich 2, J. TiibeP, R. Penning 1, and W. Eisenmenger 1 
Departments ofLegal Medicine 1 and Pathology 2, University of Munich, Frauenlobstrasse 7a, W-8000 Munich 2, Germany 
Received June 18, 1992 / Received in revised form October 30, 1992 
Summary. A total of 56 surgically treated human skin 
wounds with a wound age between 8h and 7 months were 
investigated. Tenascin was visualized by immunohisto- 
chemistry and appeared first in the wound area pericel- 
lularly around fibroblastic cells approximately 2 days 
after wounding. A network-like interstitial positive stain- 
ing pattern was first detectable in 3-day-old skin wounds. 
In all wounds with an age of 5 days or more, intensive 
reactivity for tenascin could be observed in the lesional 
area (dermal-epidermal junction, wound edge, areas of 
bleeding). In wounds with an age of more than approxi- 
mately 1.5 months no positive staining occurred in the 
scar tissue. In conclusion, for forensic purposes, positive 
staining for tenascin restricted to the pericellular area of 
fibroblastic ells indicates awound age of at least 2 days. 
Network-like structures appear after approximately 3 days 
or more. Since tenascin seems to be regularly detectable 
in skin wounds older than 5 days, the lack of a positive 
reaction in a sufficient number of specimens indicates a 
wound age of less than 5 days. The lack of a positive reac- 
tion in the granulation tissue of wounds with advanced 
wound age indicates a survival time of more than about 
1.5 months, but a positive staining in older wounds can- 
not be excluded. 
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Zusammenfassung. In 56 chirurgisch versorgten mensch- 
lichen Hautwunden mit einem Wundalter zwischen 8 
Stunden und 7 Monaten wurde Tenascin immunhisto- 
chemisch dargestellt. Erstmals war Tenascin in einer 2 
Tage alten Wunde perizellul~ir um Fibroblasten ach- 
weisbar. Netzwerk-artige, positiv reagierende Struktu- 
ren traten im Wundgebiet frfihestens nach einer Oberle- 
benszeit von 3 Tagen auf und waren in Hautwunden, die 
~ilter als 4 Tage waren, regelmfiNg anzutreffen. Mit zu- 
nehmendem Wundalter war eine Abnahme der Reakti- 
vitgt fiir Tenascin im Granulationsgewebe feststellbar 
und in den filtesten untersuchten Hautwunden (Wundal- 
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ter 2,5 bzw. 7 Monate) war kein Tenascin mehr auf3er- 
halb des iiblicherweise anf~irbbaren Strukturen zu beob- 
achten. Der perizellul~ire Nachweis yon Tenascin belegt 
somit ein Wundalter von mindestens ca. 2 Tagen, netz- 
werk-artige, positiv anf~irbbare Strukturen im Wundge- 
biet ein Wundalter von mindestens ca. 3 Tagen. Die regel- 
mfiBige Nachweisbarkeit yon Tenascin ab einem Wund- 
alter von ca. 5 Tagen gibt bei einer ausreichenden An- 
zahl von untersuchten Pr~iparaten und Fehlen einer ent- 
sprechenden Reaktion Hinweise auf eine Oberlebens- 
zeit von unter 5 Tagen. Mit zunehmendem Wundalter 
sinkt die Reaktivit~it des Granulationsgewebes fiir Te- 
nascin und eine positive Reaktion deutet auf eine Ober- 
lebenszeit bis ca. 1,5 Monate hin, eine lfingere Nachweis- 
barkeit kann jedoch nicht ausgeschlossen werden. 
Schliisselw6rter: Tenascin - Wundalter - Immunhisto- 
chemie 
Introduction 
Wound repair is a series of biological processes involving 
cellular proliferation, migration, differentiation, and tis- 
sue remodeling by the synthesis of structural compo- 
nents of the extracellular matrix such as various collagen 
subtypes. 
However, proteins of the extracellular matrix are not 
only important for advanced structural remodeling of 
the tissue, but are also involved in the early phases of 
wound healing as previously shown for fibronectin [13]. 
Tenascin is a glycoprotein of the extracellular matrix 
with a six-armed structure [9] which gave rise to the term 
hexabrachion. According to previous findings, tenascin 
has been isolated from various sources leading to a vari- 
ety of synonyms uch as myotendinous antigen, glioma 
mesenchymal extracellular matrix antigen, brachionec- 
tin, J1 and cytotactin [21]. 
Tenascin interacts with fibronectin [10, 18], supports 
the adhesion of a variety of cell types including fibro- 
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blasts and endothelial cells [5], appears to act as a cell 
adhesion molecule in particular in the central nervous 
system [17], and seems to exert immunomodulatory ac- 
tivities [25]. 
Tenascin is produced by cultured fibroblasts and mes- 
enchymal tissues [21] and is often co-localized with fibro- 
nectin, but its occurrence is much more restricted than 
that of fibronectin [7]. It is found in normal skin in as- 
sociation with epithelial and endothelial cells. Immuno- 
histochemical studies provide evidence for positive stain- 
ing of the papillary dermis immediately beneath the 
basal lamina, within the walls of blood vessels, and in 
smooth muscle bundles of the musculi arrectores pilorum. 
Strong reactivity can also be found around the cuboidal 
cells of the basal layer of sweat gland ducts [19, 26]. 
Since a time-dependent appearance in experimental 
wound healing has been shown [11, 21, 23], this study 
was performed to investigate whether the immunohisto- 
chemical ocalization of tenascin may be useful for the 
time estimation of human skin wounds. 
Material and methods 
A total of 56 human skin wounds (surgical wounds, stab wounds 
and lacerations after surgical treatment) with a wound age be- 
tween 8h and 7 months were investigated. Specimens were ob- 
tained at autopsy within a postmortem interval of less than 3 days. 
Subjects had died in traumatic events (car accidents, falls, homi- 
cides) and their ages ranged between 15 and 92 years (average age 
54 years). Only subjects without malnutrition or severe diseases 
which could have an influence on wound healing, such as c ncer or 
metabolic disorders, were selected for this study. According to 
clinical reports no substances which could influence wound heal- 
ing, such as glucocorticoids or cytotoxic agents, had been adminis- 
tered during therapy. 
From each skin wound at least 2 specimens were fixed in 4% 
PBS-formaldehyde solution andthen embedded in paraffin wax. 
Sections (thickness of 2-3 gm) were prepared, and after enzyme 
pretreatment, tenascin was visualized using a monoclonal antibody 
(Locus-Genex, Helsinki, Finland) according to theABC-method 
[14]. 
Undamaged skin from the same subjects and specimens with- 
out the inclusion of the primary antibody were used as controls. 
Results 
Undamaged skin 
In normal skin, a strong positive reaction for tenascin 
was found in the walls of blood vessels, muscle bundles 
of the musculi arrectores pilorum, nerve bundles, and 
the basal cell layer of skin appendages, in particular in 
sweat gland ducts and in papillary layer of the dermis ad- 
jacent to the basement membrane. Strong reactivity was 
also observed around the bulb of hair follicles. 
Skin wounds 
Positive staining for tenascin in the wound area was first 
detectable around fibroblastic ells in skin wounds ap- 
proximately 2 days old. The development of network-like 
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Fig.1. Wound edge of a 5-day-old skin wound: beginning forma- 
tion of network-like structures positively staining for tenascin 
(paraffin wax, 240 x, ABC-method) 
structures positive for tenascin could be localized in the 
lesional area as early as about 3 days after wounding. 
Such a distinct positive reaction could be observed in 3 
out of 10 cases (30%) with a wound age between 2 and 3 
days. In all skin wounds with a survival time of 5 days or 
more, a strong positive reaction was observed in the 
form of a network-like structure with the exception of 
the oldest wounds investigated (wound age 2.5 or 7 
months). Negative results were obtained in 2 out of 6 
(33%) skin wounds aged between 4 and 5 days; in one of 
these cases a questionable reaction was found. 
Tenascin was also detectable in the granulation tissue 
of older wounds (wound age 1.5 months) but in reduced 
amounts. In 3 out of 5 cases (60%) with a wound age of 
1.5 months or more, no reactivity for tenascin was de- 
tectable in the scar tissue. However, the capillaries in the 
scar tissue showed positive staining. 
There were no relevant differences in the time-de- 
pendent localization of tenascin between stab wounds, 
surgical wounds and lacerations. 
In our series, no significant delay in the earliest ap- 
pearance of tenascin was detectable in skin wounds ob- 
tained from older subjects, as compared to lesions from 
younger subjects, even though in some cases of advanced 
individual age a somewhat reduced staining intensity for 
this protein occurred. 
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Fig. 2. Enhanced expression of tenascin at dermal-epidermal junc- 
tion and in adjacent connective tissue of the wound edge ofan 11- 
day-old skin wound (paraffin wax,240 ×, ABC-method). 
Discussion 
Tenascin is an extracellular matrix protein mainly ex- 
pressed uring morphogenesis in embryonal life [1, 2, 8, 
9, 15, 20, 22, 27]. It reappears in malignant tumors [27], 
during inflammation and tissue repair, and plays a dis- 
tinctive role in cell adhesion [5, 10, 17, 18]. Further- 
more, tenascin exerts immunomodulatory activities by 
altering the adhesion properties of monocytes, B- and T- 
cells [25]. Tenascin contains domains homologous to epi- 
dermal growth factor, fibronectin type III repeat se- 
quence, and beta nd gamma chains of fibrinogen [16, 
24], suggesting similar properties to growth factors and 
adhesion molecules. Since it has been shown that tenas- 
cin stimulates cell proliferation in cell cultures, a mitotic 
signal function is also under discussion [9]. Tenascin may 
facilitate cell migration, and antibodies against enascin 
inhibit cell migration of cerebellar granular cells [12] or 
during the development of the neural crest in the chick 
[6]. 
These functions indicate an important role during 
biological processes and an enhanced expression during 
wound healing has been shown in experimental nimals 
[11, 21, 23]. 
Tenascin was detected first 1-3 days after wounding 
in the healing skin of the mouse [11, 23]. In rat skin 
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wounds tenascin could be found after a similar time 
period [21]. Tenascin disappeared in mouse skin lesions 
approximately 10-14 days after wounding and was still 
present in rat granulation tissue close to the dermal-epi- 
dermal junction in 10-day-old wounds. 
Mackie et al. [21] found that tenascin was not detect- 
able in the vessel walls of newly formed capillaries which 
appeared in the granulation tissue. 
In our series, tenascin was first detectable pericellu- 
larly, around fibroblasts in the wound area of skin 
wounds aged approximately 2 days and therefore consid- 
erably later than another cell adhesion protein, fibronec- 
tin, which was shown to appear first after a survival time 
of at least a few minutes [4]. Network-like structures 
were observed in 3-day-old skin lesions and such a stain- 
ing pattern was seen in all cases with a wound age of 5 
days or more, with the exception of the oldest wounds 
(post infliction interval 2.5 or 7 months). These results 
are similar to findings reported for experimental nimals 
[11, 21, 23], and the regular occurrence of tenascin in 
skin wounds of a certain age is comparable to the stain- 
ing pattern of fibronectin [4]. According to the experi- 
mental findings of Mackie et al. [21] and Chuong and 
Chen [11], tenascin seems to disappear at the point in 
time when fibronectin is still present in the granulation 
tissue [4]. 
Although a decrease in staining intensity occurred in 
our series with advanced wound age, tenascin was also 
detectable in skin wounds 1.5 months old, but could not 
be observed in the scar tissue of older wounds. 
Differences concerning the disappearance of tenascin 
between the studies of Mackie et al. [21] compared 
to those of Chuong and Chen [11] and to our findings 
may be explained by the different species in which 
the wounds were inflicted. It may therefore be assumed 
that certain biological processes proceed faster in small 
animals than in humans, although considerable differ- 
ences between experimental nimals can also be noticed 
[11]. 
With respect o a possible influence of individual age 
or the way the wounds were inflicted (sharp or blunt 
trauma), we analyzed our material for differences in the 
time-dependent appearance of tenascin in the wound 
area. In some cases with advanced individual age we 
noticed a somewhat reduced staining intensity for this 
cell adhesion protein, but relevant differences, which 
have to be considered for a forensically applicable 
wound age estimation, could not be found. Berg [3] re- 
ported that the individual age influences, in particular, 
later changes in wound healing, but is of less importance 
for the beginning of reparative changes. Furthermore, 
the kind of lesion (stab/surgical wounds versus lacera- 
tions) also seems to have less influence on the earliest 
appearance of tenascin (and probably of other repara- 
tive changes) since tissue regeneration starts in particu- 
lar from undamaged skin. On the other hand, it can be 
expected that the made of wound infliction influences - 
as the extent of the lesional area - the interval in which 
tenascin can be detected since a reduced perfusion of the 
wound area due to edema following blunt trauma of the 
skin can influence the speed of repair. 
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In summary,  our results support  the assumption that 
tenascin plays an important  role during wound healing. 
The immunohistochemica l  local izat ion of this extracel lu- 
lar matr ix prote in provides the fol lowing informat ion for 
a forensical ly appl icable t ime-est imat ion of human skin 
wounds: 
1. Tenasc in first appears  approx imate ly  2 days after 
wounding around the f lbroblast ic cells of the wound 
area. 
2. Network- l ike  structures posit ively staining for tenas- 
cin can first be expected in wounds with an age of 3 days 
or more  and seem to occur regular ly in lesions with an 
age of 5 days or more.  
3. Staining intensity for tenascin decreases in granula- 
t ion tissue with increasing wound age, but  is still present  
in skin wounds of about 1.5 months.  Since the extent of 
the lesional area inf luences the t ime per iod necessary for 
total  heal ing to occur, a lack of posit ive reactivity in the 
granulat ion tissue cannot provide further informat ion 
useful for a t ime est imat ion of skin lesions of advanced 
wound age. 
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